You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Cavatica is a project of CHOP's Center for Data Driven Discovery in Biomedicine and is part of its commitment to the Precision Medicine Initiative.
The partners will build a proof-of-concept case for a cloud platform and associated services to manage and integrate genomic data for healthcare use.
The company'sExatype software is a web-based solution for locating HIV drug resistance mutations using raw NGS data and other functional information.
Earlier this week, the company announced that it had received CE marking for OmnomicsNGS, its variant interpretation tool.
Participants are being asked to apply their mapping and variant calling pipelines to two whole genome sequence datasets and compare the results.
The developers are offering free single analysis codes to use Nephele as part of a promotion to test the features and feasibility of the system.
Data on thousands of cancers is being moved to the cloud for researchers to use.
The company is seeking partnerships that will enable it to offer its software to more users as part of larger, more integrated systems.
The funds will enable the company to take on more national-scale precision medicine projects as well as continue to support existing ones.
Both companies have made their products available on Azure, and Curoverse is collaborating with Microsoft on benchmarking tools for analysis pipelines.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.